{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:45:06Z","timestamp":1794613506419,"version":"4.9.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jhep.2024.12.041","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T07:52:02Z","timestamp":1737964322000},"page":"926-937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Update in clinical science: Autoimmune hepatitis"],"prefix":"10.1016","volume":"82","author":[{"given":"Michael A.","family":"Heneghan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8823-3129","authenticated-orcid":false,"given":"Ansgar Wilhelm","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2024.12.041_bib1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.12.041_bib2","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/jgh.14746","article-title":"Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population","volume":"34","author":"Lv","year":"2019","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102280","article-title":"Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis","volume":"65","author":"Hahn","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jhep.2024.12.041_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00281-022-00936-6","article-title":"The intestinal and biliary microbiome in autoimmune liver disease\u2014current evidence and concepts","volume":"44","author":"Liwinski","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jhep.2024.12.041_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/hep.32653","article-title":"Sociodemographic and geographic differences in the US epidemiology of autoimmune hepatitis with and without cirrhosis","volume":"77","author":"Bittermann","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.041_bib6","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"issue":"E1","key":"10.1016\/j.jhep.2024.12.041_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cgh.2020.05.061","article-title":"Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis","author":"Lamba","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2023.06.002","article-title":"Autoimmune hepatitis: epidemiology, subtypes, and presentation","volume":"1","author":"Shiffman","year":"2024","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2024.12.041_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhep.2020.03.015","article-title":"Autoimmune Hepatitis: possible triggers, potential treatments","volume":"73","author":"Herkel","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Study of Health in Pomerania. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.12.041_bib11","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.31473","article-title":"Next-generation immunosequencing reveals pathological T-cell architecture in autoimmune hepatitis","volume":"73","author":"Schulthei\u00df","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.041_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.141462","article-title":"Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver","volume":"6","author":"Preti","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhep.2024.12.041_bib13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.32417","article-title":"Chinese AIH Consortium. Genome-wide meta-analysis identifies susceptibility loci for autoimmune hepatitis type 1","volume":"76","author":"Li","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.041_bib14","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/hep.27991","article-title":"Depletion of B cells induces remission of autoimmune hepatitis in mice through reduced antigen presentation and help to T cells","volume":"62","author":"B\u00e9land","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.041_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2022.02.014","article-title":"Unexplained liver test elevations after SARS-CoV-2 vaccination","volume":"77","author":"Guardiola","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?","volume":"75","author":"Bril","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib17","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2023.05.020","article-title":"Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics","volume":"79","author":"Uzun","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib18","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.vaccine.2024.01.021","article-title":"Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data","volume":"42","author":"Kochhar","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.jhep.2024.12.041_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jhep.2023.10.009","article-title":"OCTAVE Collaborative Group, PITCH study, and the EASL supported COVID-Hep vaccine network. Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients","volume":"80","author":"Murray","year":"2024","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ueg2.12218","article-title":"SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease","volume":"10","author":"Duengelhoef","year":"2022","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jhep.2024.12.041_bib21","first-page":"381","article-title":"Evidence for spontaneous immunosuppression in autoimmune hepatitis","volume":"22","author":"Lohse","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.041_bib22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jhep.2024.12.041_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35882-7","article-title":"Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis","volume":"8","author":"Taubert","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2024.12.041_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1056\/NEJMc2311867","article-title":"JAK inhibition in STAT1 gain-of-function-mediated treatment-resistant autoimmune hepatitis","volume":"390","author":"Had\u017ei\u0107","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2024.12.041_bib25","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/j.jhep.2023.09.028","article-title":"Deleterious variants in TNFAIP3 are associated with type II and seronegative pediatric autoimmune hepatitis","volume":"80","author":"Pandurangi","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib26","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/lt.25451","article-title":"Acute severe autoimmune hepatitis: corticosteroids or liver transplantation?","volume":"25","author":"Rahim","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2024.12.041_bib27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhep.2018.05.035","article-title":"Family occurrence of autoimmune hepatitis: a Danish nationwide registry-based cohort study","volume":"69","author":"Gr\u00f8nb\u00e6k","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2020.07.032","article-title":"Update of the simplified criteria for autoimmune hepatitis: evaluation of the methodology for immunoserological testing","volume":"74","author":"Galaski","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/s-2001-12906","volume":"126","author":"Kanzler","year":"2001","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jhep.2024.12.041_bib31","article-title":"Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis","volume":"3","author":"Laschtowitz","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2024.12.041_bib32","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.15217","volume":"42","author":"Lohse","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2024.12.041_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.humpath.2018.07.014","article-title":"Histologic features of autoimmune hepatitis: a critical appraisal","volume":"82","author":"Gurung","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jhep.2024.12.041_bib34","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group","volume":"76","author":"Pape","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib35","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/HEP.0000000000000589","article-title":"Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry","volume":"79","author":"Slooter","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.041_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2024.03.021","article-title":"Treatment response and clinical event-free survival in autoimmune hepatitis: a Canadian multicentre cohort study","volume":"81","author":"Plagiannakos","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib38","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.cgh.2018.12.035","article-title":"Predniso(lo)ne dosage and chance of remission in patients with autoimmune hepatitis","volume":"17","author":"Pape","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib39","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/HEP.0000000000000018","article-title":"ColHai Registry. Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration","volume":"77","author":"D\u00edaz-Gonz\u00e1lez","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.041_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/apt.14968","article-title":"UK-AIH Consortium. Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom","volume":"48","author":"Dyson","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2024.12.041_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16035","article-title":"European reference network (ERN) RARE-LIVER. Unmet needs in autoimmune hepatitis: results of the prospective multicentre European reference network registry (R-LIVER)","author":"Schregel","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2024.12.041_bib42","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jhep.2023.11.032","article-title":"Dutch Autoimmune Hepatitis Working Group. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis","volume":"80","author":"Snijders","year":"2024","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhep.2024.01.021","article-title":"Editorial: treating Autoimmune Hepatitis - more science, more progress, better therapy","volume":"80","author":"Hirschfield","year":"2024","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib44","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/hep.32410","article-title":"Autoimmune hepatitis in pregnancy: pearls and pitfalls","volume":"76","author":"Chung","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.041_bib45","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jhep.2021.03.023","article-title":"Towards personalised medicine in autoimmune hepatitis: measurement of thiopurine metabolites results in higher biochemical response rates","volume":"75","author":"Candels","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib46","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jhep.2020.07.023","volume":"73","author":"Lohse","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/apt.16708","article-title":"Epstein-Barr virus status and immunosuppression use in paediatric autoimmune liver disease","volume":"55","author":"Nayagam","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2024.12.041_bib48","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2023.01.013","article-title":"Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood","volume":"78","author":"Maggiore","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib49","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jhep.2023.02.017","article-title":"Paediatric autoimmune hepatitis: time to change the textbooks?","volume":"78","author":"Lohse","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib50","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/MPG.0000000000003858","article-title":"Hepatology committee of the European society for paediatric gastroenterology, hepatology and nutrition. Liver biopsy is indicated before attempting treatment withdrawal in children with AIH: commentary by the ESPGHAN HepCom","volume":"77","author":"Samyn","year":"2023","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2024.12.041_bib51","article-title":"Biliary disease progression in childhood onset autoimmune liver disease: a 30-year follow-up into adulthood","volume":"6","author":"Warner","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2024.12.041_bib52","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jhep.2020.12.033","article-title":"FILFOIE consortium \u2013 France. Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: the SURFASA score","volume":"74","author":"De Martin","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/apt.16926","article-title":"Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study","volume":"56","author":"T\u00e9llez","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2024.12.041_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103113","article-title":"Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis","volume":"140","author":"Terziroli Beretta-Piccoli","year":"2023","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jhep.2024.12.041_bib55","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/j.jhep.2023.09.028","article-title":"Center for Autoimmune Liver Disease Research Group. Deleterious variants in TNFAIP3 are associated with type II and seronegative pediatric autoimmune hepatitis","volume":"80","author":"Pandurangi","year":"2024","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib56","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1056\/NEJMc2311867","article-title":"JAK inhibition in STAT1 gain-of-function-mediated treatment-resistant autoimmune hepatitis","volume":"390","author":"Had\u017ei\u0107","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2024.12.041_bib57","article-title":"Efficacy and safety of infliximab in patients with autoimmune hepatitis","author":"Efe","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.041_bib58","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep4.1889","article-title":"Noninvasive prediction of outcomes in autoimmune hepatitis-related cirrhosis","volume":"6","author":"Llovet","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2024.12.041_bib59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2003-36419","article-title":"Minilaparoscopy in the diagnosis of cirrhosis: superiority in patients with Child-Pugh A and macronodular disease","volume":"35","author":"Helmreich-Becker","year":"2003","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2024.12.041_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101325","article-title":"Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis","volume":"46","author":"Heneghan","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jhep.2024.12.041_bib61","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2016.05.023","article-title":"Transient elastography in autoimmune hepatitis: timing determines the impact of inflammation and fibrosis","volume":"65","author":"Hartl","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib62","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2023.09.010","article-title":"Dutch AIH Study Group; International Autoimmune Hepatitis Group. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"80","author":"Colapietro","year":"2024","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.12.041_bib64","article-title":"Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease","volume":"5","author":"Zachou","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2024.12.041_bib65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12072-011-9277-8","article-title":"Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN). Clinical significance of serum\u00a0autoantibodies in patients with NAFLD: results from the nonalcoholic\u00a0steatohepatitis clinical research network","volume":"6","author":"Vuppalanchi","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2024.12.041_bib66","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8446170","article-title":"Prevalence and significance of antinuclear antibodies in biopsy-proven nonalcoholic fatty liver disease: a systematic review and meta-analysis","author":"Luo","year":"2022","journal-title":"Dis Markers"},{"key":"10.1016\/j.jhep.2024.12.041_bib67","first-page":"50","article-title":"Health-related quality of life and symptoms in autoimmune liver diseases","volume":"69","author":"Janik","year":"2023","journal-title":"Minerva Gastroenterol (Torino)"},{"key":"10.1016\/j.jhep.2024.12.041_bib68","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/hep.30031","article-title":"UK-AIH consortium. The impact of autoimmune hepatitis and its treatment on health utility","volume":"68","author":"Wong","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.041_bib69","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10620-022-07525-5","article-title":"Patient priorities in autoimmune hepatitis: the need for better treatments, more education and challenging Stigma","volume":"68","author":"Lloyd","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2024.12.041_bib70","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/liv.15440","article-title":"Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE-LIVER online survey","volume":"43","author":"Wunsch","year":"2023","journal-title":"Liver Int"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824028320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824028320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:00:47Z","timestamp":1773457247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827824028320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0168827824028320"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2024.12.041","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update in clinical science: Autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}